Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Specialized Care for Esophageal and Gastric Cancers Esophageal and gastric (stomach) cancers can be very complex to diagnose and treat. Dr. Peter Enzinger, Director of the Center for Esophageal and Gastric Cancer at Dana-Farber/Brigham and Women's Cancer Center, describes how the Center brings together the expertise of many subspecialists to treat these complicated cancers.
Our director, medical oncologist Peter C. Enzinger, MD, is part of a group developing the research agenda for the United States in esophageal and gastric cancer. He has researched and developed many of the drugs and regimens considered standard today for the treatment of esophageal and gastric cancer.
Radiation oncologist Harvey Mamon, MD, PhD, spearheads research activities focused on optimizing the combination of radiation with systemic therapies, including conventional chemotherapy and newer targeted agents. He also works to identify biomarkers as prognostic or predictive factors for the response to treatment.
Thoracic surgeon Scott Swanson, MD, is one of the world's leading thoracic surgical specialists. Many of the procedures he performs, including some of the most complex techniques, use minimally invasive, image-guided approaches.
Our Chief of Gastrointestinal Pathology, Robert Odze, MD, FACP, is the editor of the textbook that's used by most pathology departments throughout the world for diagnosing esophageal cancer. He has also authored numerous important publications, improving the understanding of how these cancers develop and evolve.
See the complete list of our esophagogastric cancer specialists.
Appointments and Second Opinions